Ptprcloc/Ptprcloc
C57BL/6JSfdAnu-Ptprcloc/AnuApb
|
abnormal B cell number |
J:104190
|
abnormal double-positive T cell morphology |
J:104190
|
abnormal memory T cell number |
J:104190
|
abnormal T cell morphology |
J:104190
|
abnormal T cell selection |
J:104190
|
abnormal thymocyte activation |
J:104190
|
arrested T cell differentiation |
J:104190
|
decreased CD4-positive, alpha-beta T cell number |
J:104190
|
decreased CD8-positive, alpha-beta T cell number |
J:104190
|
decreased double-positive T cell number |
J:104190
|
decreased T cell number |
J:104190
|
Ptprcltng/Ptprcltng
C57BL/6-Ptprcltng
|
abnormal T cell differentiation |
J:158876
|
decreased CD4-positive, alpha-beta T cell number |
J:158876
|
decreased double-positive T cell number |
J:158876
|
thymus hypoplasia |
J:158876
|
Ptprcltng/Ptprctm1Mak
involves: 129/Sv * C57BL/6
|
abnormal T cell differentiation |
J:158876
|
decreased CD4-positive, alpha-beta T cell number |
J:158876
|
decreased double-positive T cell number |
J:158876
|
thymus hypoplasia |
J:158876
|
Ptprcm1Btlr/Ptprcm1Btlr
involves: C57BL/6J
|
absent T cells |
J:152064
|
Ptprcm1Smv/Ptprcm1Smv
involves: C57BL/6J * C57BL/10J
|
abnormal CD4-positive T cell differentiation |
J:214487
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:214487
|
abnormal immune system cell morphology |
J:214487
|
abnormal immune system physiology |
J:214487
|
CNS inflammation |
J:214487
|
decreased DN4 thymocyte number |
J:214487
|
increased DN3 thymocyte number |
J:214487
|
increased double-negative T cell number |
J:214487
|
increased susceptibility to Herpesvirales infection |
J:214487
|
Ptprcm2Btlr/Ptprcm2Btlr
C57BL/6J-Ptprcm2Btlr
|
abnormal humoral immune response |
J:216796
|
decreased B-1a cell number |
J:216796
|
decreased B-2 B cell number |
J:216796
|
decreased CD4-positive, alpha-beta memory T cell number |
J:216796
|
decreased CD8-positive, alpha-beta memory T cell number |
J:216796
|
decreased mature B cell number |
J:216796
|
decreased memory B cell number |
J:216796
|
decreased memory T cell number |
J:216796
|
decreased single-positive T cell number |
J:216796
|
increased B-1 B cell number |
J:216796
|
increased B-1b cell number |
J:216796
|
increased dendritic cell number |
J:216796
|
increased neutrophil cell number |
J:216796
|
increased single-positive T cell number |
J:216796
|
Ptprcm3Btlr/Ptprcm3Btlr
C57BL/6J-Ptprcm3Btlr
|
decreased B cell number |
J:254899
|
decreased B-1a cell number |
J:254899
|
decreased B-2 B cell number |
J:254899
|
decreased CD8-positive, alpha-beta T cell number |
J:254899
|
increased B-1b cell number |
J:254899
|
Ptprcm4Btlr/Ptprcm4Btlr
C57BL/6J-Ptprcm4Btlr
|
decreased B cell number |
J:264808
|
decreased CD4-positive, alpha-beta T cell number |
J:264808
|
decreased CD8-positive, alpha-beta T cell number |
J:264808
|
decreased CD8-positive, naive alpha-beta T cell number |
J:264808
|
decreased single-positive T cell number |
J:264808
|
decreased T cell number |
J:264808
|
increased B-1 B cell number |
J:264808
|
increased central memory CD4-positive, alpha-beta T cell number |
J:264808
|
increased central memory CD8 positive, alpha-beta T cell number |
J:264808
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:264808
|
increased effector memory CD8-positive, alpha-beta T cell number |
J:264808
|
PtprcM5Btlr/PtprcM5Btlr
C57BL/6J-PtprcM5Btlr
|
increased alpha-beta T cell number |
J:265143
|
PtprcM6Btlr/PtprcM6Btlr
C57BL/6J-PtprcM6Btlr
|
decreased B-1a cell number |
J:265186
|
decreased B-1b cell number |
J:265186
|
decreased CD8-positive, naive alpha-beta T cell number |
J:265186
|
increased B-1 B cell number |
J:265186
|
Ptprcm7Btlr/Ptprcm7Btlr
C57BL/6J-Ptprcm7Btlr
|
decreased alpha-beta T cell number |
J:267486
|
decreased B cell number |
J:267486
|
decreased CD4-positive, alpha-beta T cell number |
J:267486
|
decreased CD8-positive, alpha-beta T cell number |
J:267486
|
decreased CD8-positive, naive alpha-beta T cell number |
J:267486
|
decreased NK T cell number |
J:267486
|
increased B-1 B cell number |
J:267486
|
increased central memory CD4-positive, alpha-beta T cell number |
J:267486
|
increased central memory CD8 positive, alpha-beta T cell number |
J:267486
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:267486
|
increased effector memory CD8-positive, alpha-beta T cell number |
J:267486
|
PtprcM8Btlr/PtprcM8Btlr
C57BL/6J-PtprcM8Btlr
|
increased B-1 B cell number |
J:267487
|
increased central memory CD8 positive, alpha-beta T cell number |
J:267487
|
PtprcM9Btlr/PtprcM9Btlr
C57BL/6J-PtprcM9Btlr
|
abnormal B cell differentiation |
J:272745
|
abnormal CD8-positive, alpha beta T cell morphology |
J:272745
|
abnormal lymphocyte morphology |
J:272745
|
decreased B cell number |
J:272745
|
decreased NK cell number |
J:272745
|
decreased systemic arterial systolic blood pressure |
J:272745
|
increased CD8-positive, alpha-beta T cell number |
J:272745
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:272745
|
PtprcM10Btlr/PtprcM10Btlr
C57BL/6J-PtprcM10Btlr
|
decreased B-1b cell number |
J:272777
|
decreased IgE level |
J:272777
|
PtprcM11Btlr/PtprcM11Btlr
C57BL/6J-PtprcM11Btlr
|
abnormal B cell differentiation |
J:274863
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:274863
|
increased B-1 B cell number |
J:274863
|
Ptprcm12Btlr/Ptprcm12Btlr
C57BL/6J-Ptprcm12Btlr
|
decreased B cell number |
J:274972
|
decreased CD4-positive, alpha-beta T cell number |
J:274972
|
decreased CD8-positive, alpha-beta T cell number |
J:274972
|
decreased CD8-positive, naive alpha-beta T cell number |
J:274972
|
decreased central memory CD8 positive, alpha-beta T cell number |
J:274972
|
decreased effector memory CD4-positive, alpha-beta T cell number |
J:274972
|
decreased T cell number |
J:274972
|
increased B-1 B cell number |
J:274972
|
Ptprcnim/Ptprcnim
C57BL/6JAnu-Ptprcnim
|
decreased B cell number |
J:225105
|
decreased leukocyte cell number |
J:225105
|
decreased T cell number |
J:225105
|
Ptprcrain/Ptprcrain
C57BL/6JAnu-Ptprcrain/AnuApb
|
abnormal leukocyte morphology |
J:104190
|
Ptprcstrm/Ptprcstrm
C57BL/6JAnu-Ptprcstrm/AnuApb
|
decreased B cell number |
J:104190
|
decreased T cell number |
J:104190
|
Ptprctm1Holm/Ptprctm1Holm
involves: 129/Sv * C57BL/6
|
abnormal B cell number |
J:33466
|
abnormal lymphopoiesis |
J:33466
|
abnormal T cell differentiation |
J:33466
|
decreased CD4-positive, alpha-beta T cell number |
J:33466
|
decreased CD8-positive, alpha-beta T cell number |
J:33466
|
decreased double-positive T cell number |
J:33466
|
decreased T cell number |
J:33466
|
decreased thymocyte number |
J:33466
|
increased double-negative T cell number |
J:33466
|
spleen hyperplasia |
J:33466
|
Ptprctm1Mak/Ptprctm1Mak
B6.Cg-Ptprctm1Mak
|
abnormal CD4-positive, alpha-beta intraepithelial T cell morphology |
J:111646
|
abnormal intraepithelial T cell morphology |
J:111646
|
abnormal intraepithelial T cell number |
J:111646
|
abnormal NK cell physiology |
J:109462
|
abnormal T cell differentiation |
J:111646
|
decreased cytotoxic T cell cytolysis |
J:111646
|
decreased gamma-delta intraepithelial T cell number |
J:111646
|
increased T cell apoptosis |
J:111646
|
Ptprctm1Mak/Ptprctm1Mak
involves: 129
|
abnormal bone marrow cell morphology/development |
J:141275
|
abnormal long bone metaphysis morphology |
J:141275
|
abnormal myelination |
J:104929
|
abnormal oligodendrocyte morphology |
J:104929
|
abnormal osteoclast morphology |
J:141275
|
abnormal osteoclast physiology |
J:141275
|
decreased mast cell degranulation |
J:110782
|
decreased oligodendrocyte number |
J:104929
|
decreased susceptibility to type I hypersensitivity reaction |
J:110782
|
Ptprctm1Mak/Ptprctm1Mak
involves: 129/Sv * C57BL/6
|
abnormal response to infection |
J:13163
|
abnormal T cell subpopulation ratio |
J:13163
|
arrested T cell differentiation |
J:158876
|
decreased B cell proliferation |
J:13163
|
decreased CD4-positive, alpha-beta T cell number |
J:13163
|
decreased CD8-positive, alpha-beta T cell number |
J:13163
|
decreased cytotoxic T cell cytolysis |
J:13163
|
decreased T cell number |
J:13163
|
decreased T cell proliferation |
J:13163
|
decreased thymocyte number |
J:13163
|
increased double-negative T cell number |
J:13163
|
Ptprctm1Tyb/Ptprctm1Tyb
129S2/SvPas-Ptprctm1Tyb
|
diarrhea |
J:57681
|
lethality at weaning, incomplete penetrance |
J:57681
|
Ptprctm1Tyb/Ptprctm1Tyb
B6.129S2-Ptprctm1Tyb
|
abnormal chemokine secretion |
J:98190
|
abnormal cytokine secretion |
J:98190
|
abnormal NK cell physiology |
J:98190
|
increased NK cell number |
J:98190
|
Ptprctm1Tyb/Ptprctm1Tyb
C.129S2-Ptprctm1Tyb
|
abnormal positive T cell selection |
J:57681
|
abnormal T cell differentiation |
J:57681
|
abnormal T cell physiology |
J:57681
|
decreased CD4-positive, alpha-beta T cell number |
J:57681
|
decreased CD8-positive, alpha-beta T cell number |
J:57681
|
decreased double-positive T cell number |
J:57681
|
enlarged spleen |
J:57681
|
normal
hematopoietic system phenotype |
J:57681
|
normal
immune system phenotype |
J:57681
|
increased double-negative T cell number |
J:57681
|
normal
mortality/aging |
J:57681
|
thymus hypoplasia |
J:57681
|
Ptprctm1Tyb/Ptprctm1Tyb
involves: 129S2/SvPas * C57BL/6 * DBA/2
|
no abnormal phenotype detected |
J:57681
|
Ptprctm1Weis/Ptprc+
involves: 129X1/SvJ * C57BL/6
|
increased anti-double stranded DNA antibody level |
J:66501
|
increased IgG2a level |
J:66501
|
increased susceptibility to autoimmune disorder |
J:66501
|
increased urine protein level |
J:66501
|
premature death |
J:66501
|
Ptprctm1Weis/Ptprctm1Weis
B6.129X1-Ptprctm1Weis
|
abnormal B cell activation |
J:147129
|
abnormal double-positive T cell morphology |
J:147129
|
abnormal follicular B cell physiology |
J:147129
|
abnormal T cell activation |
J:147129
|
abnormal T cell subpopulation ratio |
J:147129
|
abnormal thymocyte activation |
J:147129
|
decreased follicular B cell number |
J:147129
|
enlarged lymph nodes |
J:147129
|
normal
immune system phenotype |
J:109462
|
increased memory T cell number |
J:147129
|
increased plasma cell number |
J:147129
|
increased transitional stage B cell number |
J:147129
|
liver inflammation |
J:147129
|
lung inflammation |
J:147129
|
Ptprctm1Weis/Ptprctm1Weis
involves: 129X1/SvJ * C57BL/6
|
abnormal B cell activation |
J:66501
|
abnormal digestion |
J:66501
|
abnormal erythropoiesis |
J:66501
|
abnormal granulocyte differentiation |
J:66501
|
abnormal immune system organ morphology |
J:66501
|
abnormal leukocyte cell number |
J:66501
|
abnormal T cell activation |
J:66501
|
enlarged lymph nodes |
J:66501
|
enlarged spleen |
J:66501
|
extramedullary hematopoiesis |
J:66501
|
glomerulonephritis |
J:66501
|
increased anti-double stranded DNA antibody level |
J:66501
|
increased B cell number |
J:66501
|
increased IgA level |
J:66501
|
increased IgG2a level |
J:66501
|
increased plasmacytoid dendritic cell number |
J:66501
|
increased spleen red pulp amount |
J:66501
|
increased spleen white pulp amount |
J:66501
|
increased susceptibility to autoimmune disorder |
J:66501
|
increased T cell number |
J:66501
|
increased urine protein level |
J:66501
|
kidney failure |
J:66501
|
lymph node hyperplasia |
J:66501
|
oliguria |
J:66501
|
premature death |
J:66501
|